측방유동분석법 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 기술별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Lateral Flow Assays Market Size, Share & Trends Analysis Report By Product (Kits, Lateral Flow Readers), By Application (Clinical Testing, Veterinary Diagnostics), By Technique, By End-use, By Region, And Segment Forecasts, 2025 - 2033

US $ 5,950 ￦ 8,710,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,174,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,102,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

측방유동분석법 시장 : 개요

세계의 측방유동분석법 시장 규모는 2024년에 98억 5,000만 달러로 추정되며, 2033년까지 174억 4,000만 달러에 달할 것으로 예측됩니다.

2025년부터 2033년까지 CAGR 6.98%로 성장할 것으로 예상됩니다. 감염성 질환의 발생률 증가, 분석 설계 및 제조 기술의 지속적인 발전, 재택 의료 및 현장 진단 검사에서 신속 진단 검사의 도입 확대 등의 요인이 이러한 추세를 촉진하고 있습니다.

세계보건기구(WHO)의 보고에 따르면, 2023년까지 전 세계적으로 약 2억 6,300만 건의 말라리아가 발생할 것으로 예상되며, 이는 측면 흐름 검사와 같은 신속하고 저비용의 고정밀 진단 제품의 필요성을 강조하고 있습니다. 기술의 발전으로 측면 흐름 분석(LFA)의 성능과 용도가 향상되고 있습니다. 민감도 및 특이성 향상, 다중화 기술, 스마트폰 앱 및 클라우드 연결 장치를 통한 디지털 응용 등이 포함됩니다. 후자의 발전으로 측면 흐름 장치는 감염 탐지 이외의 분야, 예를 들어 임신 검사, 심장 질환 모니터링, 수의학 진단, 환경 검사, 식품 안전 등에도 활용되고 있습니다.

이러한 발전의 일환으로 영국의 애빙던 헬스(Abingdon Health)는 측면 흐름 산업의 선두주자로 자리매김하고 있습니다. 2024년 5월, 애빙던 헬스(Abingdon Health)는 영국에서 부트사 자체 브랜드의 타액을 이용한 임신 자가진단 키트를 출시하였습니다. 본 제품은 살리노스틱스 및 크레스트 메디컬을 통해 온라인으로도 판매되고 있습니다. 이는 기존의 소변 검사 방식의 임신 검사에서 비침습적 타액 검사로 기술적으로 전환하여 사용자의 편의성과 접근성을 높인 것을 의미합니다. 제품 출시와 더불어, 이 획기적인 제품 혁신은 부츠 자체 브랜드 라인에 타액 임신 자가 테스트 키트를 채택한 최초의 기업으로서 아빈슨 헬스와 부츠의 전략적 제휴를 더욱 강화할 수 있는 계기가 되었습니다. 이러한 발전은 생명공학 혁신, 소비자 건강, 전략적 제휴가 세계 LFA 시장의 방향성에 지속적으로 영향을 미치고 있음을 보여줍니다.

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 측방유동분석법 시장 : 변수, 동향, 범위

• 시장 개요/연관 전망
• 시장 규모와 성장 전망
• 시장 역학
• 측방유동분석법 시장 : 분석 툴
  • Porter's Five Forces 분석
  • PESTEL 분석
  • 파이프라인
  • 사례 연구

제4장 측방유동분석법 시장 : 제품별 추정·동향 분석

• 측방유동분석법 시장 : 변동 분석 : 제품별
• 측방유동분석법 시장, 추정치·예측치 : 제품별(단위 : 100만 달러·1,000개, 2024년·2033년)
• 키트·시약
• 측방유동 리더
  • 벤치탑 리더
  • 디지털 리더

제5장 측방유동분석법 시장 : 용도별 추정·동향 분석

• 측방유동분석법 시장 : 변동 분석 : 용도별
• 측방유동분석법 시장, 추정치·예측치 : 용도별(단위 : 100만 달러·1,000개, 2024년·2033년)
• 임상 검사
  • 감염증 검사
  • 심장 마커 검사
  • 임신·불임 검사
  • 콜레스테롤 검사/지질 프로파일
  • 약물 남용 검사
  • 기타 임상 검사
• 동물 진단
• 식품 안전·환경 검사
• 의약품 개발·품질 검사

제6장 측방유동분석법 시장 : 기술별 추정·동향 분석

• 측방유동분석법 시장 : 변동 분석 : 기술별
• 측방유동분석법 시장, 추정치·예측치 : 기술별(단위 : 100만 달러·1,000개, 2024년·2033년)
• 샌드위치 분석법
• 경쟁 분석법
• 다중 검출 어세이

제7장 측방유동분석법 시장 : 최종 용도별 추정·동향 분석

• 측방유동분석법 시장 : 변동 분석 : 최종 용도별
• 측방유동분석법 시장, 추정치·예측치 : 최종 용도별(단위 : 100만 달러·1,000개, 2024년·2033년)
• 병원·진료소
• 진단 검사실
• 재택의료
• 제약·바이오테크놀러지 기업
• 기타 최종 용도

제8장 측방유동분석법 시장 : 지역별 추정·동향 분석

• 측방유동분석법 시장 : 시장 점유율, 지역별(100만 달러, 2024년·2033년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제9장 경쟁 구도

• 최신 동향과 영향 분석 : 주요 시장 진입 기업별
• 기업 분류
• 기업 히트맵 분석
• 기업 개요
  • Abbott
  • Bio-Rad Laboratories, Inc
  • Siemens Healthineers AG
  • BIOMERIEUX
  • BD
  • QIAGEN
  • QuidelOrtho Corporation
  • F. Hoffmann-La Roche
  • DH Life Sciences, LLC.
  • Quest Diagnostics

KSM

영문 목차

영문목차

Lateral Flow Assays Market Summary

The global lateral flow assays market size was estimated at USD 9.85 billion in 2024 and is projected to reach USD 17.44 billion by 2033, growing at a CAGR of 6.98% from 2025 to 2033. Factors including the growing incidence of infectious diseases, ongoing technological advances in assay design and manufacturing, and the increased implementation of rapid diagnostic tests in home care and point-of-care testing facilitate this trend.

Infectious diseases remain one of the main global health challenges; for example, the World Health Organization (WHO) reported 263 million estimated malaria cases around the world in 2023, highlighting the need for rapid, inexpensive, and accurate diagnostic products such as lateral flow tests. Technological advancements now allow for improved performance and use of lateral flow assays (LFAs), including advances in sensitivity, specificity, multiplexing, and digital applications via smartphone apps and cloud-connected devices. The latter advances have meant that lateral flow devices may be used in areas outside infectious disease detection, including pregnancy testing, heart disease monitoring, veterinary diagnostics, environmental testing, and food safety.

As part of the advances above, Abingdon Health plc (UK) has established itself as a key player in the lateral flow industry. In May 2024, Abingdon Health plc launched Boots' own-brand saliva-based pregnancy self-test in the United Kingdom and online via Salignostics and Crest Medical. This product represents a technological shift from traditional urine-based pregnancy tests to non-invasive saliva testing, thus providing greater convenience and accessibility for the user. In addition to launching the product, the significant advancement in product innovation provided an opportunity to further strengthen Abingdon Health's strategic partnership with Boots as the first company to adapt a saliva pregnancy self-test into Boots' own-brand range. These advances demonstrate how biotechnology innovation, consumer health, and strategic partnerships continue to influence the direction of the global LFAs market.

Global Lateral Flow Assays Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global lateral flow assays market report based on product, application, technique, end use, and region:

• Product Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
• Kits & Reagents
• Lateral Flow Readers
  • Digital/Mobile Readers
  • Benchtop Readers
• Application Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
• Clinical Testing
  • Infectious Diseases Testing
• COVID-19 Testing
• Mosquito Borne Disease Testing
• Influenza Testing
• Sexually Transmitted Infection Testing
  • HIV Testing
  • HPV Testing
  • Chlamydia Testing
  • Gonorrhea Testing
  • Syphilis Testing
  • Others
• Hepatitis
• Tuberculosis
• Others
  • Cardiac Marker Testing
• Troponin I and T Testing
• CK-MB Testing
• BNP and NT-proBNP Testing
• Myoglobin Testing
• D-Dimer Testing
• Others
  • Pregnancy & Fertility Testing
• Pregnancy Testing
• Fertility Testing
  • Cholesterol Testing/Lipid Profile Testing
  • Drugs of Abuse Testing
  • Others
• Veterinary Diagnostics
• Food safety & Environment Testing
• Drug Development & Quality Testing
• Technique Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
• Sandwich Assays
• Competitive Assays
• Multiplex Detection Assays
• End Use Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care
• Pharmaceutical & Biotechnology Companies
• Others
• Regional Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Lateral Flow Assay Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million, Volume, in thousands)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
    • 3.3.1.1. Increasing prevalence of infectious diseases
    • 3.3.1.2. Technological advancements in lateral flow
    • 3.3.1.3. Growing adoption in homecare settings
  • 3.3.2. Market Restraints Analysis
    • 3.3.2.1. Stringent Regulations
  • 3.3.3. Market Opportunities Analysis
    • 3.3.3.1. Growing demand for Point-of-Care (POC) Testing
    • 3.3.3.2. Expanding applications beyond healthcare
  • 3.3.4. Market Challenges Analysis
    • 3.3.4.1. Product Recalls
• 3.4. Lateral Flow Assay Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape
  • 3.4.3. Pipeline
  • 3.4.4. Case Study

Chapter 4. Lateral Flow Assay Market: Product Estimates & Trend Analysis

• 4.1. Lateral Flow Assay Market: Product Movement Analysis
• 4.2. Lateral Flow Assay Market Estimates and Forecasts, by Product (USD Million, Volume in thousands), 2024 & 2033
• 4.3. Kits & Reagents
  • 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
• 4.4. Lateral Flow Readers
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 4.4.2. Benchtop Readers
    • 4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 4.4.3. Digital Readers
    • 4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)

Chapter 5. Lateral Flow Assay Market: Application Estimates & Trend Analysis

• 5.1. Lateral Flow Assay Market: Application Movement Analysis
• 5.2. Lateral Flow Assay Market Estimates and Forecasts, by Application (USD Million, Volume in thousands), 2024 & 2033
• 5.3. Clinical Testing
  • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 5.3.2. Infectious Disease Testing
    • 5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.2.2. COVID-19
      • 5.3.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.2.3. Mosquito Borne Disease Testing
      • 5.3.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.2.4. Influenza Testing
      • 5.3.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.2.5. Sexually Transmitted Infection Testing
      • 5.3.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
      • 5.3.2.5.2. HIV Testing
        • 5.3.2.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
      • 5.3.2.5.3. HPV Testing
        • 5.3.2.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
      • 5.3.2.5.4. Chlamydia Testing
        • 5.3.2.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
      • 5.3.2.5.5. Gonorrhea Testing
        • 5.3.2.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
      • 5.3.2.5.6. Syphilis Testing
        • 5.3.2.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
      • 5.3.2.5.7. Other STI Testing
        • 5.3.2.5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.2.6. Hepatitis
      • 5.3.2.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.2.7. Tuberculosis
      • 5.3.2.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.2.8. Other Infectious Diseases
      • 5.3.2.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 5.3.3. Cardiac Marker Testing
    • 5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.3.2. Troponin I and T Testing
      • 5.3.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.3.3. CK-MB Testing
      • 5.3.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.3.4. BNP and NT-Probnp Testing
      • 5.3.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.3.5. Myoglobin Testing
      • 5.3.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.3.6. D-Dimer Testing
      • 5.3.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.3.7. Other Cardiac Marker Tests
      • 5.3.3.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 5.3.4. Pregnancy & Fertility Testing
    • 5.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.4.2. Pregnancy Testing
      • 5.3.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
    • 5.3.4.3. Fertility Testing
      • 5.3.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 5.3.5. Cholesterol Testing/Lipid Profile
    • 5.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 5.3.6. Drugs of Abuse Testing
    • 5.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 5.3.7. Other Clinical Tests
    • 5.3.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
• 5.4. Veterinary Diagnostics
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
• 5.5. Food Safety & Environment Testing
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
• 5.6. Drug Development & Quality Testing
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)

Chapter 6. Lateral Flow Assay Market: Technique Estimates & Trend Analysis

• 6.1. Lateral Flow Assay Market: Technique Movement Analysis
• 6.2. Lateral Flow Assay Market Estimates and Forecasts, by Technique (USD Million, Volume in thousands), 2024 & 2033
• 6.3. Sandwich Assays
  • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
• 6.4. Competitive Assays
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
• 6.5. Multiplex Detection Assays
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)

Chapter 7. Lateral Flow Assay Market: End Use Estimates & Trend Analysis

• 7.1. Lateral Flow Assay Market: End Use Movement Analysis
• 7.2. Lateral Flow Assay Market Estimates and Forecasts, by End Use (USD Million, Volume in thousands), 2024 & 2033
• 7.3. Hospitals & Clinics
  • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
• 7.4. Diagnostic Laboratories
  • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
• 7.5. Home Care
  • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
• 7.6. Pharmaceutical & Biotechnology Companies
  • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
• 7.7. Other End Use
  • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)

Chapter 8. Lateral Flow Assay Market: Regional Estimates & Trend Analysis

• 8.1. Lateral Flow Assay Market Share, By Region, 2024 & 2033, USD Million
• 8.2. North America
  • 8.2.1. North America Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.2.2. U.S.
    • 8.2.2.1. Key Country Dynamics
    • 8.2.2.2. Competitive Scenario
    • 8.2.2.3. Regulatory Framework
    • 8.2.2.4. Reimbursement Scenario
    • 8.2.2.5. U.S. Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.2.3. Canada
    • 8.2.3.1. Key Country Dynamics
    • 8.2.3.2. Competitive Scenario
    • 8.2.3.3. Regulatory Framework
    • 8.2.3.4. Reimbursement Scenario
    • 8.2.3.5. Canada Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.2.4. Mexico
    • 8.2.4.1. Key Country Dynamics
    • 8.2.4.2. Competitive Scenario
    • 8.2.4.3. Regulatory Framework
    • 8.2.4.4. Reimbursement Scenario
    • 8.2.4.5. Mexico Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
• 8.3. Europe
  • 8.3.1. Europe Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.3.2. UK
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. Reimbursement Scenario
    • 8.3.2.5. UK Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.3.3. Germany
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Reimbursement Scenario
    • 8.3.3.5. Germany Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.3.4. France
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Reimbursement Scenario
    • 8.3.4.5. France Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.3.5. Italy
    • 8.3.5.1. Key Country Dynamics
    • 8.3.5.2. Competitive Scenario
    • 8.3.5.3. Regulatory Framework
    • 8.3.5.4. Reimbursement Scenario
    • 8.3.5.5. Italy Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.3.6. Spain
    • 8.3.6.1. Key Country Dynamics
    • 8.3.6.2. Competitive Scenario
    • 8.3.6.3. Regulatory Framework
    • 8.3.6.4. Reimbursement Scenario
    • 8.3.6.5. Spain Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.3.7. Denmark
    • 8.3.7.1. Key Country Dynamics
    • 8.3.7.2. Competitive Scenario
    • 8.3.7.3. Regulatory Framework
    • 8.3.7.4. Reimbursement Scenario
    • 8.3.7.5. Denmark Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.3.8. Sweden
    • 8.3.8.1. Key Country Dynamics
    • 8.3.8.2. Competitive Scenario
    • 8.3.8.3. Regulatory Framework
    • 8.3.8.4. Reimbursement Scenario
    • 8.3.8.5. Sweden Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.3.9. Norway
    • 8.3.9.1. Key Country Dynamics
    • 8.3.9.2. Competitive Scenario
    • 8.3.9.3. Regulatory Framework
    • 8.3.9.4. Reimbursement Scenario
    • 8.3.9.5. Norway Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
• 8.4. Asia Pacific
  • 8.4.1. Asia Pacific Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.4.2. Japan
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. Reimbursement Scenario
    • 8.4.2.5. Japan Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.4.3. China
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Reimbursement Scenario
    • 8.4.3.5. China Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.4.4. India
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Reimbursement Scenario
    • 8.4.4.5. India Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.4.5. Australia
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Reimbursement Scenario
    • 8.4.5.5. Australia Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.4.6. South Korea
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Reimbursement Scenario
    • 8.4.6.5. South Korea Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.4.7. Thailand
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Reimbursement Scenario
    • 8.4.7.5. Thailand Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
• 8.5. Latin America
  • 8.5.1. Latin America Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.5.2. Brazil
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Reimbursement Scenario
    • 8.5.2.5. Brazil Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.5.3. Argentina
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Reimbursement Scenario
    • 8.5.3.5. Argentina Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
• 8.6. Middle East and Africa
  • 8.6.1. Middle East and Africa Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.6.2. South Africa
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Reimbursement Scenario
    • 8.6.2.5. South Africa Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.6.3. Saudi Arabia
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Reimbursement Scenario
    • 8.6.3.5. Saudi Arabia Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.6.4. UAE
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. Reimbursement Scenario
    • 8.6.4.5. UAE Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)
  • 8.6.5. Kuwait
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Reimbursement Scenario
    • 8.6.5.5. Kuwait Lateral Flow Assay Market Estimates and Forecasts, 2021 - 2033 (USD Million, Volume in thousands)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis by Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Heat Map Analysis
• 9.4. Company Profiles
  • 9.4.1. Abbott
    • 9.4.1.1. Participant's Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Recent Developments/ Strategic Initiatives
  • 9.4.2. Bio-Rad Laboratories, Inc
    • 9.4.2.1. Participant's Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Recent Developments/ Strategic Initiatives
  • 9.4.3. Siemens Healthineers AG
    • 9.4.3.1. Participant's Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Recent Developments/ Strategic Initiatives
  • 9.4.4. BIOMERIEUX
    • 9.4.4.1. Participant's Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Recent Developments/ Strategic Initiatives
  • 9.4.5. BD
    • 9.4.5.1. Participant's Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Recent Developments/ Strategic Initiatives
  • 9.4.6. QIAGEN
    • 9.4.6.1. Participant's Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Recent Developments/ Strategic Initiatives
  • 9.4.7. QuidelOrtho Corporation
    • 9.4.7.1. Participant's Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Recent Developments/ Strategic Initiatives
  • 9.4.8. F. Hoffmann-La Roche
    • 9.4.8.1. Participant's Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Recent Developments/ Strategic Initiatives
  • 9.4.9. DH Life Sciences, LLC.
    • 9.4.9.1. Participant's Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Recent Developments/ Strategic Initiatives
  • 9.4.10. Quest Diagnostics
    • 9.4.10.1. Participant's Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Recent Developments/ Strategic Initiatives

관련자료